Mark your calendars for October 22nd, 1:00 PM EST! Join us for a webinar on "Introduction to the Gene and Cellular Therapy Era." We’ll delve into the latest in gene and cellular therapies, their unique challenges, and the innovative business models emerging to address them. Register now to gain insights into current therapies, payer considerations, and what’s on the horizon in this critical area of healthcare. Be part of the conversation that shapes the future of patient care. https://bit.ly/47EkSEw #ElevatingSpecialtyPharmacy #ShieldsRx
Shields Health Solutions’ Post
More Relevant Posts
-
Join us on Tuesday, October 22nd, from 1:00 to 2:00 PM EST for our webinar, "Introduction to the Gene and Cellular Therapy Era." This session will explore the unique challenges these therapies present in healthcare delivery and the innovative solutions emerging in response. Register now to deepen your understanding of current FDA-approved therapies, operational considerations, and evolving payment models. Don’t miss this opportunity to be part of this transformative discussion! https://bit.ly/47EkSEw #ElevatingSpecialtyPharmacy #ShieldsRx
To view or add a comment, sign in
-
Today’s the day! Join us at 1:00 PM EST for our webinar, "Introduction to the Gene and Cellular Therapy Era." We’ll explore the latest advancements, innovative payment models, and the challenges gene and cellular therapies bring to healthcare. There’s still time to register—don’t miss out on this important conversation! https://bit.ly/47EkSEw #ElevatingSpecialtyPharmay #ShieldsRx
To view or add a comment, sign in
-
Interested in learning how the #AdvancedTherapies industry can enhance today's manufacturing practices to establish fully automated, digitally integrated processes? ➡️ https://buff.ly/3BthKPL Daniel Gibson, Head of Collaborations at the Cell and Gene Therapy Catapult, highlights this and more in his key takeaways from Phacilitate's recent Advanced Therapies Europe event. Read the blog ☝️ #CellTherapy #GeneTherapy #ATMPs
To view or add a comment, sign in
-
The clinical research process is made up of phases - typically 4. At every phase, the goal is to determine if a treatment or drug is both SAFE and EFFECTIVE for humans. Each phase has specific goals, asks different questions and builds upon what was learned in the earlier phase(s). This video by the American Society of Gene & Cell Therapy describes the basic framework. https://bit.ly/40mUe1t #clinicaltrials #research #raredisease
To view or add a comment, sign in
-
Robust diagnostic panels inferred via network analysis:
Modern anti-cancer treatments are effective in only a minority of patients, with known determinants of treatment response offering only partial explanations. Attempts to enhance this knowledge using omics data have faced challenges. Our approach leverages network-level analysis and fuzzy set theory to develop a novel generation of biomarkers. The method, NeaMarker maps patient-specific gene signatures to characteristic pathways, creating diagnostic panels for predicting treatment outcomes. Learn more here: https://lnkd.in/dAKEe-dA #cancerresearch #biomarkers #precisionmedicine #TreatmentResponse #networks #NetworkAnalysis
To view or add a comment, sign in
-
Our webinar 'Developing a robust target product profile (TPP) for successful therapy adoption' which we hosted last week is now available to view on-demand! Tune in to hear from Cell and Gene Therapy Catapult experts in market access, regulatory affairs, and non-clinical strategy talking through the resource, discussing the value of a TPP and how to approach building one as an early-stage therapy developer. Watch it here: https://buff.ly/41LxQNE #TPP #AccessStrategy #AdvancedTherapies #clinical
To view or add a comment, sign in
-
Cell, gene and advanced therapies have the potential to revolutionize the treatment landscape and even cure previously incurable diseases. In this webinar, our experts discuss how strategically integrated connected systems specifically tailored for these treatments can optimize outcomes across the patient’s care continuum. Register now: https://bit.ly/3A4U2Zv
To view or add a comment, sign in
-
Modern anti-cancer treatments are effective in only a minority of patients, with known determinants of treatment response offering only partial explanations. Attempts to enhance this knowledge using omics data have faced challenges. Our approach leverages network-level analysis and fuzzy set theory to develop a novel generation of biomarkers. The method, NeaMarker maps patient-specific gene signatures to characteristic pathways, creating diagnostic panels for predicting treatment outcomes. Learn more here: https://lnkd.in/dAKEe-dA #cancerresearch #biomarkers #precisionmedicine #TreatmentResponse #networks #NetworkAnalysis
To view or add a comment, sign in
-
Exciting Event Alert: Accelerating Science Forum on Longevity and Compliance in Cell and Gene Therapies! 🧬 Join us for a groundbreaking online forum dedicated to the future of healthcare - exploring the latest advancements in cell and gene therapies. Discover how we're tackling longevity and compliance, pushing the boundaries of science to pave the way for new treatments and therapies that could transform lives. 📅 Don't miss this opportunity to connect with leading experts, gain insights into cutting-edge research, and be part of the conversation shaping the future of medicine. Whether you're a scientist, healthcare professional, or just passionate about the next frontier in healthcare innovation, this event is for you. 💡 Learn from the pioneers driving forward these revolutionary therapies, engage in meaningful discussions, and network with professionals from across the globe - all from the comfort of your home or office. Register now to secure your spot in this not-to-be-missed forum and be at the forefront of accelerating science in cell and gene therapies! #CellTherapy #GeneTherapy #HealthcareInnovation #ScienceForum #Longevity #Compliance #MedicalResearch #OnlineEvent
Save the date! Attend our forum with SelectScience on Feb 27 at 16:00 GMT for a deep dive into the longevity and compliance of cell and gene therapies. We'll cover key topics like safety, efficacy, manufacturing and regulatory hurdles. Whether you're a researcher, healthcare pro, or industry enthusiast, gain insights into the future of medicine. Register here: https://hubs.li/Q02ll5Df0
To view or add a comment, sign in
-
#longevitymedicine and compliance of #cellandgenetherapy #webinaralert Don't miss this panel live in 6 days' time, but even if you can't make it, register anyway and you'll receive a link to watch on demand.
Save the date! Attend our forum with SelectScience on Feb 27 at 16:00 GMT for a deep dive into the longevity and compliance of cell and gene therapies. We'll cover key topics like safety, efficacy, manufacturing and regulatory hurdles. Whether you're a researcher, healthcare pro, or industry enthusiast, gain insights into the future of medicine. Register here: https://hubs.li/Q02ll5Df0
To view or add a comment, sign in
21,650 followers